Skip to main content
. 2022 Jun 14;23(1):1376. doi: 10.4102/sajhivmed.v23i1.1376

TABLE 3.

Sequence of anti-tuberculosis drug rechallenge.

Rechallenge regimen Participants
n %
RIF → INH → PZA 38 50
INH → RIF → PZA 6 8
RIF → INH 26 30
INH → RIF 4 5
RIF → PZA 1 1
INH → PZA 1 1
RIF 3 5

INH, isoniazid; PZA, pyrazinamide; RIF, rifampicin.

, One participant was rechallenged with RIF and INH concomitantly, followed by PZA.

, One participant was rechallenged with RIF, PZA and INH concomitantly.